- A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
-
Ko KJ, Jenkins B, Patel A, Lee KS
- KMID: 2446744
- Int Neurourol J.
- 2019 Mar;23(1):30-39.
- doi: 10.5213/inj.1836176.088
PURPOSE: OnabotulinumtoxinA has demonstrated efficacy and safety in the treatment of urinary incontinence (UI) associated with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (OAB); however, real-world evidence is limited.... -
- CITED
-
- Close
- SHARE
-
- Close
